NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Devices · USD

Integer Holdings Corporation (ITGR) Stock Analysis

Integer Holdings Corporation (ITGR) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

ITGR

$126.50

+$1.00 (+0.80%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ITGR with… →

ITGR Key Statistics

As of Sep 4, 2026
Trading
Open
$125.84
Previous Close
$125.50
Day's Range
125.84–126.80
52-Week Range
62.00–126.75
Volume
1.61M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.61
Valuation
Market Cap
$4.30B
P/E Ratio
34.66
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.42
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.79
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.33
EPS (ttm)Profit attributable to each share over the last twelve months.
3.65
Financials (FY)
Revenue (FY)
$1.85B+7.98%
Net Income (FY)
$102.81M−14.25%
Profit marginThe share of revenue left as profit after all costs and taxes.
6.97%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
33.99M
1-Year Return
+18.67%
Dividend and dates
Earnings Date
October 29, 2026estimated
Avg Volume
892.02K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

ITGR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+61.29%
2025−40.82%
2024+33.75%
2023+44.73%
2022−20.01%
2021+5.42%
2020+0.94%
2019+5.47%
2018+68.34%
2017+53.82%
2016 (partial year)+23.38%

As of September 4, 2026.

ITGR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.85B$102.81M5.5%
2024$1.72B$119.90M7.0%
2023$1.56B$90.65M5.8%
2022$1.33B$66.38M5.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.85B$500.39M$239.14M$102.81M5.5%
2024$1.72B$459.01M$220.39M$119.90M7.0%
2023$1.56B$409.89M$174.75M$90.65M5.8%
2022$1.33B$345.76M$127.95M$66.38M5.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ITGR Valuation vs Medical Devices Median

Median of 151 stocks
MetricITGRMedical Devices medianvs median
P/E34.6626.8029% above
P/S ratio2.332.9822% below
Profit margin6.97%−1.69%8.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Integer Holdings Corporation (ITGR) at $4.30B. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 11,000 employees.

The 52-week range on file runs from $62.00 to $126.75. ITGR last closed at $126.50 on September 4, 2026. That is +$1.00 (+0.80%) against the previous close. The latest close sits 104.03% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $1.85B. That is +7.98% against the prior fiscal year, when revenue was $1.72B. The same year closed with net income of $102.81M. That is −14.25% against the prior fiscal year. The reported profit margin is 6.97%. That is 8.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 3.65.

Across the 4 fiscal years on file, revenue moves from $1.33B in 2022 to $1.85B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 34.66. That is 29.33% above the Medical Devices median of 26.8. On forward earnings the ratio is 18.42. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.79. Measured against sales, the shares trade at 2.33 times revenue. On price-to-sales that is 21.62% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The reported beta is 0.62. Annualized volatility over the trailing 10 years is 38.41%. Over the trailing twelve months the price has returned +18.67%. Measured over 10 years, that is +17.84% a year compounded.

Growth & Income

No dividend is on file for ITGR.

Across the complete calendar years on file, 2018 returned +68.34% and 2025 returned −40.82%. Of the 9 complete calendar years on file, 7 finished higher. So far in 2026 the price is +61.29%.

Peer Comparison

Integer Holdings Corporation (ITGR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Integer Holdings Corporation ITGR $4.30B 34.7
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Integer Holdings Corporation trades at a P/E of 34.7.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Integer Holdings Corporation

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Visit website →